Logo Logo
Switch Language to German
Powles, T.; McDermott, D. F.; Rini, B.; Motzer, R. J.; Atkins, M. B.; Fong, L.; Joseph, R. W.; Pal, S. K.; Ravaud, A.; Bracarda, S.; Suarez Rodriguez, C.; Maio, M.; Gore, M.; Grünwald, V.; Stähler, M.; Qiu, J.; Thobhani, A.; Huseni, M.; Schiff, C.; Escudier, B. (2017): IMmotion150: Novel radiological endpoints and updated data from a randomized phase II trial investigating atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC). In: Annals of Oncology, Vol. 28
Full text not available from 'Open Access LMU'.